These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9147353)

  • 1. Percutaneous estradiol gel with an intrauterine levonorgestrel releasing device or natural progesterone in hormone replacement therapy.
    Suvanto-Luukkonen E; Sundström H; Penttinen J; Läärä E; Pramila S; Kauppila A
    Maturitas; 1997 Apr; 26(3):211-7. PubMed ID: 9147353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid effects of an intrauterine levonorgestrel device or oral vs. vaginal natural progesterone in post-menopausal women treated with percutaneous estradiol.
    Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A
    Arch Gynecol Obstet; 1998; 261(4):201-8. PubMed ID: 9789651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
    Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-binding protein-1: a biochemical marker of endometrial response to progestin during hormone replacement therapy.
    Suvanto-Luukkonen E; Sundström H; Penttinen J; Kauppila A; Rutanen EM
    Maturitas; 1995 Nov; 22(3):255-62. PubMed ID: 8746884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device.
    Raudaskoski TH; Tomás EI; Paakkari IA; Kauppila AJ; Laatikainen TJ
    Maturitas; 1995 Jun; 22(1):47-53. PubMed ID: 7666816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The levonorgestrel intrauterine system in menopausal hormone replacement therapy: five-year experience.
    Suvanto-Luukkonen E; Kauppila A
    Fertil Steril; 1999 Jul; 72(1):161-3. PubMed ID: 10428167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
    Suvisaari J; Lähteenmäki P
    Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
    Raudaskoski T; Tapanainen J; Tomás E; Luotola H; Pekonen F; Ronni-Sivula H; Timonen H; Riphagen F; Laatikainen T
    BJOG; 2002 Feb; 109(2):136-44. PubMed ID: 11888095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial suppression with a new 'frameless' levonorgestrel releasing intrauterine system in perimenopausal and postmenopausal women: a pilot study.
    Wildemeersch D; Schacht E
    Maturitas; 2000 Jul; 36(1):63-8. PubMed ID: 10989243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 5-year follow-up study on the use of a levonorgestrel intrauterine system in women receiving hormone replacement therapy.
    Varila E; Wahlström T; Rauramo I
    Fertil Steril; 2001 Nov; 76(5):969-73. PubMed ID: 11704119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding.
    Lethaby AE; Cooke I; Rees M
    Cochrane Database Syst Rev; 2000; (2):CD002126. PubMed ID: 10796865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the effects of intrauterine progestin system and oral progestin on health-related quality of life and Kupperman index in hormone replacement therapy.
    Pirimoglu ZM; Ozyapi AG; Kars B; Buyukbayrak EE; Solak Y; Karsidag AY; Unal O; Turan MC
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1376-81. PubMed ID: 21599801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
    Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
    Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine or oral administration of levonorgestrel in combination with estradiol to perimenopausal women--effects on lipid metabolism during 12 months of treatment.
    Andersson K; Stadberg E; Mattsson LA; Rybo G; Samsioe G
    Int J Fertil Menopausal Stud; 1996; 41(5):476-83. PubMed ID: 8934257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.